This journal article examines the risks patients face in seeking experimental stem cell-based interventions from clinics outside the United States. The authors advocate for new public policies that encourage patients to remain in clinical trials in the U.S. Published in BMC Medical Ethics: http://bit.ly/1WCSyW6.
